Covance Central Laboratory Services , INC

Covance Central Laboratory Services , INC was paid $105K by Medicaid between May 2020 and Jul 2021, across 2 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 98% of everything it billed.

33Billing provider infoCOVANCE CENTRAL LABORATORY SERVICES , INC
INDIANAPOLIS, IN 46214

33aNPI1720616469assigned 03/30/2020

33bProvider typeClinical Medical Laboratory

28Total paid$105K

24GClaims6,547

24DCodes billed2

24AFirst – last monthMay 2020 – Jul 2021

Compared with peers

Next to other Clinical Medical Laboratory providers in Indiana

Rank by total paid#31 of 66

Median peer was paid$53K

This provider vs. median2.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	5,538	$25K
2021	1,009	$80K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	98%	6,480	6,001	$104K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.5%	67	61	$2K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)

Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →

Provider	Location	Paid
Laboratory Corporation of America Holdings	Burlington, NC	$1.44B
Laboratory Corporation of America Holdings	Raritan, NJ	$717.47M
Laboratory Corporation of America Holdings	Dublin, OH	$617.02M
Laboratory Corporation of America Holdings	Birmingham, AL	$289.12M
Laboratory Corporation of America	Phoenix, AZ	$265.90M
Laboratory Corporation of America Holdings	Burlington, NC	$264.26M
Laboratory Corporation of America Holdings	Charleston, WV	$220.04M
Laboratory Corporation of America	Seattle, WA	$186.69M
Laboratory Corporation of America	Tampa, FL	$171.13M
Laboratory Corporation of America	San Diego, CA	$147.14M
Laboratory Corporation of America	Houston, TX	$103.81M
Laboratory Corporation of America	Englewood, CO	$77.80M
Laboratory Corporation of America	Dallas, TX	$77.42M
Laboratory Corporation of America	Burlington, NC	$59.75M
Medtox Laboratories, INC	Saint Paul, MN	$47.72M
Laboratory Corporation of America Holdings	Burlington, NC	$15.65M
Laboratory Corporation of America	San Antonio, TX	$11.67M
Tri-Cities Laboratory, LLC	Kennewick, WA	$8.69M
Laboratory Corporation of America Holdings	Monroe, LA	$3.39M
Laboratory Corporation of America	Itasca, IL	$3.37M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.